RICHMOND, Va., Jan. 7, 2026 /PRNewswire/ -- Alps Dx today announced its official launch as an innovative diagnostics tooling and automation company focused on improving the speed, safety, and scalability of oral fluid drug testing and beyond. The company enters the market with a leadership team of industry veterans and a clear commitment to addressing longstanding inefficiencies in pre-analytical workflows that have limited the adoption and reliability of oral fluid testing across clinical and forensic settings.

RICHMOND, Va. and RENO, Nev., Jan. 26, 2026 /PRNewswire/ -- Alps Dx and Hamilton Company today announced the showcase of Alps Dx Atelier, an automated system designed to streamline and standardize the preanalytical stage of oral fluid drug testing. This instrument will be showcased at the Alps Dx booth at the SLAS 2026 conference in Boston, Mass. Built on the Hamilton MICROLAB® STARlet liquid handling platform, Alps Dx Atelier integrates patented technologies, dedicated modules, consumables, and workflow software developed by Alps Dx specifically for oral fluid applications.

 RICHMOND, Va., July 23, 2026 /PRNewswire/ -- Alps Dx today announced it will debut Xpressor™ by Alps Dx, a new filtration with capping device created to make oral fluid sample preparation faster, safer, and more consistent, during the Association for Diagnostics & Laboratory Medicine (ADLM) 2026 Annual Meeting & Clinical Lab Expo. The product was developed in direct response to long-standing challenges in forensic and clinical toxicology laboratories, where current manual methods require several handling steps that slow operations and increase the potential for error.